Luca Bolliger

Luca Bolliger has a diverse work experience in the biotech and pharmaceutical industries. Luca is the owner and founder of abcDNA GmbH, a company established in 2020. Prior to that, they served as the VP of Business Development and Licensing at Arcturus Therapeutics. Luca also held leadership positions at Swiss Biotech Association, including President of the Swiss Biotech Success Stories Jury and Vice President. Their roles at Axoltis pharma included Chief Business Officer and Independent Supervisory Board Member. Luca served as a Non-Executive Board Member at Lean Molecules AG and as the VP of Corporate Licensing at Recordati. Luca was also part of the Intellisness Scientific Committee. In previous positions, they served as the Director of Business Development at NovImmune, Director of Business Development at Actelion Ltd, and Managing Director at Biopolo Ticino. Overall, Luca Bolliger has a strong background in business development, licensing, and leadership roles in the biotech and pharmaceutical industries.

Luca Bolliger's education history begins with attending Liceo scientifico bellinzona, although the specific duration and degree information are not provided. Later, they pursued a Master's degree in Biochemistry and Molecular Biology at ETH Zürich from 1986 to 1991. Luca continued their education at the same institution and obtained an MSc in Biochemistry in the same period. Moving forward, Luca completed their PhD in Biochemistry at the University of Basel between 1991 and 1994. In 1999, they attended IMD and completed a program called "Managing the innovation process." Then, in 2001, they briefly attended the London Business School for the ADP 42 program.